SHAREHOLDER ALERT: TAL BIRD FULC: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

NEW YORK, NY / ACCESSWIRE / May 29, 2023 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.

TAL Education Group (NYSE:TAL)

If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/tal-education-class-action-submission-form?prid=39994&wire=1
Lead Plaintiff Deadline: May 30, 2023
This lawsuit is on behalf of persons or entities who purchased or otherwise acquired TAL American Depository Shares between June 14, 2022 and March 14, 2023, both dates inclusive.

Allegations against TAL include that: (1) the Company was still providing services relating to academic subjects to students from kindergarten through grade nine; and (2) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all times.

Allbirds, Inc. (NASDAQ:BIRD)

If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/allbirds-class-action-submission-form?prid=39994&wire=1
Lead Plaintiff Deadline: June 12, 2023
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Allbirds Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's November 2021 initial public offering; and/or (b) Allbirds securities between November 4, 2021 and March 9, 2023, inclusive.

Allegations against BIRD include that: (1) Allbirds was overemphasizing products that extended beyond the Company's core offerings; (2) the Company's non-core products had a narrower appeal and were not resonating with customers as well as the Company's core products; (3) Allbirds was underinvesting in its core consumers' favorite products to push the Company's newer products with narrower appeal; (4) underinvesting in Allbirds' core products was negatively impacting the Company's sales; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Fulcrum Therapeutics, Inc. (NASDAQ:FULC)

If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/fulcrum-class-action-submission-form?prid=39994&wire=1
Lead Plaintiff Deadline: June 27, 2023
Class Period: March 3, 2022 - March 8, 2023

Allegations against FULC include that: (i) the preclinical data submitted in support of FTX-6058 (an investigational oral fetal hemoglobin inducer for the treatment of sickle cell disease and other hemoglobinopathies) showed safety concerns regarding potential hematological malignancies; (ii) the foregoing safety concerns increased the likelihood that the FDA would place a clinical hold on preclinical studies of FTX-6058; (iii) accordingly, the Company had overstated FTX-6058's clinical and/or commercial prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

The Law Offices of Vincent Wong, Monday, May 29, 2023, Press release picture

To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.

Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]

SOURCE: The Law Offices of Vincent Wong



View source version on accesswire.com:
https://www.accesswire.com/757844/SHAREHOLDER-ALERT-TAL-BIRD-FULC-The-Law-Offices-of-Vincent-Wong-Reminds-Investors-of-Important-Class-Action-Deadlines

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).